Skip to main content

BIO-TECHNE Corp statistics

  • TECH · Nasdaq
  • Biotechnology
  • Life Sciences Tools & Services
  • S&P 500
$72.80−0.05%Close 13 Nov 2026

Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.

Valuation

Enterprise value$11.37B
EV / EBITDA33.68
EV / sales9.26

Share price

Latest close$72.80
Day's change−0.1%
52-week high$72.88
52-week low$43.20
From 52-week high−0.1%
Return · 1 month+0.3%
Return · 3 months+0.7%
Return · year to date+23.8%
Return · 1 year+18.6%
Beta · 1 year against the S&P 5000.64
50-day average$72.53
200-day average$63.38
RSI 1459.8
Average volume · 20 sessions2.9M

Margins and returns

For fiscal 2026, as filed.

Gross margin65.8%
Operating margin20.7%
Net margin15.0%
Free cash flow margin21.7%
Return on equity9.0%
Return on assets7.4%
Return on invested capital8.5%
Return on capital employed10.5%
Stock-based compensation / revenue3.4%

Financial position

At the end of fiscal 2026.

Cash and equivalents$264.7M
Total debt$289.1M
Net debt$24.38M
Current ratio4.55
Debt / equity0.14
Net debt / EBITDA0.07
Interest coverage26.16

Shares and dividends

For fiscal 2026, as filed.

Diluted shares157M
Net share repurchases−$38.94M
Dividends per share$0.32
Dividend payout27.5%

Taxes

For fiscal 2026, as filed.

Income tax expense$58.82M
Effective tax rate24.4%

TECH in the terminal

Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.